Inhibition of RL male 1 tumor growth in BALB/c mice by introduction of the RLakt gene coding for antigen recognized by cytotoxic T-lymphocytes and the GM-CSF gene by in vivo electroporation.
D000818:Animals; D000951:Antigens, Neoplasm / Q000235:genetics* / Q000276:immunology; D019496:Cancer Vaccines; D045744:Cell Line, Tumor; D018274:Electroporation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics* / Q000276:immunology; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009842:Oligopeptides / Q000235:genetics* / Q000276:immunology; D010957:Plasmids; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D019444:Vaccines, DNA
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D009842:Oligopeptides; D019444:Vaccines, DNA; C465204:pRL1a protein, mouse; D016178:Granulocyte-Macrophage Colony-Stimulating Factor